Baxalta spinoff was successful, Baxter's financial results fell substantially in 2022-23 on external pressures, such as inflation and weak medical utilization trends. With medical utilization rising, ...

Pharma industry groups are sounding the alarm, warning that President Donald Trump’s tariffs could worsen drug shortages, ...

What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.

Tariffs and price inflation for specialty medications will increase costs, according to research from Vizient.

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

Potential impacts of the tariffs include higher prices for drugs and medical supplies, and possible shortages.

“A 25% tariff on Canada and Mexico threatens to upend the very supply chains that have made U.S. manufacturing more ...

APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

Kentucky health care providers say a drug discount program called 340B is a lifeline but it's under fire from several corners ...

The highly anticipated 3rd edition of Pharma Live Expo & Summit 2025, a premier event for the global pharmaceutical, healthcare, and MedTech sectors, will be held from 17th to 19th April 2025 at the ...

Patients in the United States pay the highest prescription drug prices in the world — on average four times what people in ...